معرفی
Jamie Cooper is Sir John Monash Distinguished Professor in the School of Public Health and Preventive Medicine at Monash University and Senior Specialist in Intensive Care at The Alfred Hospital, Melbourne. He is also an Honorary Professorial Fellow at The George Institute for Global Health, University of Sydney, reflecting his national and international academic stature.
- BMBS, MD – Medical qualifications
- FRACP, FCICM – Fellowships in Royal Australasian College of Physicians and College of Intensive Care Medicine
Professor Cooper's research centers on high-impact randomized clinical trials in critical care, with a focus on traumatic brain injury (TBI), sepsis, acute lung injury, resuscitation fluids, and blood transfusion. His work has fundamentally changed clinical practice, particularly through the landmark DECRA trial, which demonstrated that early decompressive craniectomy worsens long-term outcomes in diffuse TBI. This finding has been incorporated into global guidelines and recognized among the most important studies in neurology and critical care by Yale, Harvard, and Oxford.
His recent publications reveal a continued emphasis on ECMO outcomes, TBI recovery metrics, transfusion practices, and innovative interventions like bicarbonate therapy and early mobilization during ECMO. These studies span top journals such as Critical Care Explorations, Neurocritical Care, Circulation: Heart Failure, and Scientific Reports, showcasing interdisciplinary collaboration and methodological rigor.
Scientific Awards:
- Officer of the Order of Australia (AO), 2017
- Research Australia GSK Award for Research Excellence (ARE), 2021
- Fellow of the Australian Academy of Health and Medical Sciences (FAHMS), 2015
- AMREP Research Prize (2011, 2016)
- Australian and New Zealand Intensive Care Society CTG Chair Award, 2014
- David Sloane Prize for Best Free Paper, 2004
Professor Cooper has led or co-investigated over 61 research projects and secured more than $101 million in competitive funding, including 48 NHMRC/MRFF grants. His leadership in multicenter trials such as RECOMMEND, SODA-BIC, REDEEM, and FEISTY II highlights his role in building national critical care research infrastructure. He mentors numerous researchers and collaborates globally, particularly through the International ECMO Network (ECMONet) and CENTER-TBI.
He is actively involved in major research teams including the Australian and New Zealand Intensive Care Society Clinical Trials Group and leads a robust research program integrating clinical innovation with public health impact, contributing to UN Sustainable Development Goals in health and well-being.
